Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial
Titel:
Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial
Auteur:
Park, Yeon Hee Kim, Tae-Yong Kim, Gun Min Kang, Seok Yun Park, In Hae Kim, Jee Hyun Lee, Kyoung Eun Ahn, Hee Kyung Lee, Moon Hee Kim, Hee-Jun Kim, Han Jo Lee, Jong In Koh, Su-Jin Kim, Ji-Yeon Lee, Kyung-Hun Sohn, Joohyuk Kim, Sung-Bae Ahn, Jin-Seok Im, Young-Hyuck Jung, Kyung Hae Im, Seock-Ah